TY  - GEN
AU  - Kim,Y W
AU  - Kim,Y K
AU  - Lee,J Y
AU  - Chang,K T
AU  - Lee,H J
AU  - Kim,D-K
AU  - Sheen,Y Y
TI  - Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug
SN  - 0049-8254
PY  - 2008///1003
KW  - Administration, Oral
KW  - Animals
KW  - Benzamides
KW  - administration & dosage
KW  - Biological Transport
KW  - drug effects
KW  - Caco-2 Cells
KW  - Chromatography, Liquid
KW  - Dogs
KW  - Enzyme Inhibitors
KW  - Half-Life
KW  - Haplorhini
KW  - Humans
KW  - Imidazoles
KW  - Injections, Intravenous
KW  - Magnetic Resonance Spectroscopy
KW  - Male
KW  - Mass Spectrometry
KW  - Mice
KW  - Models, Biological
KW  - Protein Serine-Threonine Kinases
KW  - antagonists & inhibitors
KW  - Quinoxalines
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Receptor, Transforming Growth Factor-beta Type I
KW  - Receptors, Transforming Growth Factor beta
KW  - Tissue Distribution
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1080/00498250701781924
ER  -